Clinical Trials Sponsored by Ebewe Pharma GmbH

Total 332 results

Prof. Dr. Wolfgang Wick
Essex Pharma GmbH

Completed

Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive or Recurrent Glioblastoma (DIRECTOR)

Glioblastoma

Germany, Austria, Switzerland
Gerhard Garhofer
Croma-Pharma GmbH

Completed

Evaluation of the Corneal Residence Time of Chitosan-N-acetylcysteine Eye Drops in Patients With Dry Eye Syndrome After Single and Multiple Instillation

Dry Eye Syndrome

Austria
Dr. Claudia Bösmüller
Astellas Pharma GmbH

Completed

Effectiveness and Safety of Campath in Combination With Tacrolimus Monotherapy to Prevent Kidney Graft Rejection

Kidney Transplantation

Austria
National Heart and Lung Institute
Dr. Falk Pharma GmbH

Unknown

Ursodeoxycholic Acid in Chronic Heart Failure

Heart Failure, Congestive

United Kingdom
Medical University of Vienna
Roche Pharma AG; Allcyte GmbH

Recruiting

Comprehensive Genomic Profiling and Next Generation Functional Drug Screening for Patients With Aggressive Haematological Malignancies (EXALT-2)

Refractory Acute Myeloid Leukemia | Advanced Lymphoma | Refractory Lymphoma | Refractory Leukemia | Refractory T-Cell Lymphoma

Austria
Maastricht University Medical Center
MEDA Pharma GmbH & Co. KG

Terminated

Imiquimod Treatment of CIN Lesions (TOPIC)

Cervical Intraepithelial Neoplasia

Netherlands
Jomaa Pharma GmbH
Centre de Recherche Médicale de Lambaréné

Unknown

Evaluation of Fosmidomycin and Piperaquine in the Treatment of Acute Falciparum Malaria (FOSPIP)

Oral Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria
UCB BIOSCIENCES GmbH
Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's Disease

Advanced Parkinson's Disease

Australia, Korea, Republic of, Malaysia, Singapore, Taiwan
UCB Pharma
SCHWARZ BIOSCIENCES GmbH - Part of UCB Group

Completed

A Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects With Painful Diabetic Neuropathy

Painful Diabetic Neuropathy

Germany
UCB Pharma
SCHWARZ BIOSCIENCES GmbH - Part of UCB Group

Completed

A Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Diabetic Neuropathy

Painful Diabetic Neuropathy

Germany
Nutrin GmbH
Mittal Global Clinical Trial Services; Galaxa Pharma

Completed

NGA-01 Gel for the Treatment of Osteoarthritis With Joint Pain

Arthritis Osteoarthritis

India
Neupharma Srl
Sintesi Research Srl; Pari Pharma GmbH; Aptuit

Completed

Open-label, Dose-escalation Study to Evaluate the Pharmacokinetics of Inhaled Teicoplanin in Cystic Fibrosis Patients

Cystic Fibrosis

Italy
Merck Sharp & Dohme LLC
Centocor, Inc.; Essex Pharma GmbH

Completed

Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)(COMPLETED)

Psoriasis
UCB BIOSCIENCES GmbH
Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's Disease

Advanced Idiopathic Parkinson's Disease

Korea, Republic of, United States, Malaysia, Singapore, Taiwan
Dr. Claudia Bösmüller
Astellas Pharma GmbH

Completed

Simultaneous Pancreas-kidney Transplantation With Campath Protocol

Pancreas-Kidney Transplantation

Austria
MEDA Pharma GmbH & Co. KG
ICON plc; Clinipace Worldwide; Trium Analysis Online GmbH

Terminated

Tepilta® Versus Oxetacaine, Antacids and Placebo

Radiation-induced Oesophagitis

Germany, Austria
Palleos Healthcare GmbH
Roche Pharma AG; University Hospital, Essen; University Hospital Erlangen; Phaon...

Active, not recruiting

Study to Compare a Mono Atezolizumab Window Followed by a Atezolizumab - CTX Therapy With Atezolizumab - CTX Therapy (neoMono)

Triple-negative Breast Cancer

Germany
Fundación Pública Andaluza para la gestión de la...
Gebro Pharma GmbH

Unknown

Time-based Register and Analysis of COPD Endpoints (TRACE)

COPD

Spain
Hospital Universitario Dr. Jose E. Gonzalez
Ever Neuro Pharma GmbH

Recruiting

Effect of Cerebrolysin on the Blood Brain Barrier in Patients With Diabetes and Ischemic Stroke

Diabetes Mellitus, Type 2 | Ischemic Stroke, Acute | Blood Brain Barrier

Mexico
Teva Pharma GmbH

Completed

A Study to Evaluate the Effect of Ovaleap® on the Pregnancy Rate and Clinical Effects as Well as the User-friendliness of the Ovaleap®-Pen.

Pregnancy Rate | Oocytes

Germany
UCB BIOSCIENCES GmbH
Pharmaceutical Health Sciences; Bracket Global

Completed

A Study to Compare the Adhesiveness of 2 Different Rotigotine Patches Used for the Treatment of Parkinson's Disease

Parkinson's Disease

Germany
Jomaa Pharma GmbH
Hospital Clinic of Barcelona; Fundacio Clinic Barcelona

Completed

Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated P.Falciparum Malaria in Children

Malaria

Mozambique
Advanz Pharma
AMS Advanced Medical Services GmbH; APCER Life Sciences

Completed

Collection of Data of Ceftobiprole Treated Patients: Comparison of Patients With and Without Certain Diseases (RETRACE)

Hepatic Insufficiency | Renal Insufficiency | Immunosuppression

Spain, France, Germany, Italy
Teva Pharma GmbH

Completed

Study to Evaluate Satisfaction and Usability of DuoResp® SPIROMAX® in Asthma and COPD Treatment

Patient Satisfaction

Germany
Radboud University Medical Center
Hoffmann-La Roche; Astellas Pharma GmbH

Completed

Rituximab for Prevention of Rejection After Renal Transplantation

Kidney Transplantation

Netherlands
AM-Pharma
CRM Biometrics GmbH; Sintesi Research Srl; Vigilex BV

Completed

Safety/Efficacy Study of Bovine Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative Colitis

Ulcerative Colitis

Czech Republic, Italy
UCB BIOSCIENCES GmbH
Schwarz BioSciences GmbH; Alfred-Nobel-Str. 10; 40789 Monheim am Rhein

Completed

Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects

Healthy

Germany
MEDA Pharma GmbH & Co. KG
ClinResearch, GmbH; Trio Clinical Research, LLC, Raleigh, USA; NuCara Pharmacy... and other collaborators

Completed

Relative Potency of Formoterol Novolizer® 12 µg Compared to Formoterol Aerolizer® 12 µg

Asthma

United States
Leti Pharma GmbH
Pierrel Research Europe GmbH; Laboratorios LETI SL (Study Medication); Labor...

Completed

Dose Finding Study for Depigoid Birch: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma

Allergic Rhinitis and/or Rhinoconjunctivitis +- Asthma | Immunotherapy, Allergen

Germany, Lithuania, Poland
Correvio International Sarl
PrimeVigilance; AMS Advanced Medical Services GmbH

Terminated

Xydalba Utilization Registry in Germany

Bacterial Infections

Germany
University of Göttingen
Roche Pharma AG; Mundipharma Research GmbH & Co KG

Completed

Rituximab and Bendamustine in Very Elderly Patients or Elderly Medically Non Fit Patients With Aggressive B-cell Lymphoma (B-R-ENDA)

Aggressive Lymphoma

Germany
Medical University of Vienna
National Bank of Austria; Biotest Pharma GmbH

Terminated

The Impact of IVIG Treatment on Critical Illness Polyneuropathy and/or Myopathy in Patients With MOF and SIRS/Sepsis (CIPNM)

Polyneuropathies

Austria
Federal University Teaching Hospital, Feldkirch...
MEDA Pharma GmbH & Co. KG

Completed

Imiquimod and Actinic Keratoses: an Observational Study

Actinic Keratosis
Charite University, Berlin, Germany
Bristol-Myers Squibb; Pierre Fabre Pharma GmbH

Unknown

Study for Patients With Non Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

Germany
Ever Neuro Pharma GmbH
Excel PharmaStudies, Inc.; idv Datenanalyse und Versuchsplanung

Completed

The Safety and Efficacy of Cerebrolysin in Patients With Acute Ischemic Stroke (CASTA)

Ischemic Stroke

Korea, Republic of, China, Hong Kong
University Hospital, Ghent
MEDA Pharma GmbH & Co. KG; University of Wuerzburg

Withdrawn

Study to Analyse Difference in Bioavailability Between MP29-02 and Fluticasone Propionate (BIODYMF)

Bioavailability Study

Belgium
Mucos Pharma GmbH and Co

Completed

The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients

HIV Infections

United States
AIO-Studien-gGmbH
Roche Pharma AG; Immodulon Therapeutics Ltd

Recruiting

Atezolizumab in Patients With MSI-h/MMR-D Stage III Colorectal Cancer Ineligible for Oxaliplatin (ANTONIO)

Colorectal Cancer

Germany
Ever Neuro Pharma GmbH
IDV Data analysis and study planning Dr. Rahlfs

Recruiting

Cerebrolysin REGistry Study in Stroke - a High-quality Observational Study of Comparative Effectiveness (C-REGS2)

Acute Ischemic Stroke

Austria
Institut für Klinische Krebsforschung IKF GmbH...
Roche Pharma AG

Recruiting

Study of Atezolizumab + FLOT vs. FLOT Alone in Patients With GC/GEJ and High Immune Responsiveness (DANTE)

Gastric Cancer | Gastroesophageal Junction Adenocarcinoma

Germany, Switzerland
Clinical Institute of the Brain, Russia
Ever Neuro Pharma GmbH; Nycomed; Veropharm

Completed

Navigation Brain Stimulation for Evaluation of the Neuroprotective Drug Efficiency in Patients After Ischemic Stroke. (3C)

Stroke

Russian Federation
MEDA Pharma GmbH & Co. KG
Quintiles, Inc.; Ergomed; Clinquest, Inc.

Completed

Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) (NATHAN1)

Diabetic Polyneuropathy

United States, Spain, Croatia, Denmark, France, Italy, Netherlands, Sweden, United Kingdom
University Medical Center Groningen
Isala; Wörwag Pharma GmbH & Co. KG; Predictions Network

Completed

Benfotiamine in Diabetic Nephropathy (Benfo)

Diabetic Nephropathy

Netherlands
Institut für Klinische Krebsforschung IKF GmbH...
EUSA Pharma, Inc.

Recruiting

Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With Leiomyosarcoma (DiTuSarc)

Leiomyosarcoma

Germany
Institut für Klinische Krebsforschung IKF GmbH...
Roche Pharma AG

Recruiting

PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study) (PLATON)

Stomach Cancer | Pancreatic Cancer | Cholangiocarcinoma | Gallbladder Cancer | Hepatocellular Cancer | Oesophageal Cancer

Germany
University of Kiel
Deutsche Forschungsgemeinschaft, Bonn, Germany; Novartis Pharma GmbH, Nürnberg...

Completed

Pimecrolimus and Epidermal Barrier Function

Atopic Dermatitis

Germany
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Sponsor GmbH

Completed

A Clinical Trial of Freeze-dried Human Rabies Vaccine (MRC-5 Cells)

Rabies Vaccine Adverse Reaction

China
German CLL Study Group
Roche Pharma AG; Celgene; Mundipharma Research GmbH & Co KG

Completed

A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide in Patients With Chronic Lymphocytic Leukemia (CLL2P)

Chronic Lymphocytic Leukemia

Germany
University of Ulm
GlaxoSmithKline; WiSP Wissenschaftlicher Service Pharma GmbH; German CLL Study...

Terminated

Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG)

Thrombocytopenia | Chronic Lymphocytic Leukemia

Austria, Germany
AIO-Studien-gGmbH
Taiho Pharmaceutical Co., Ltd.; Nordic Pharma SAS

Completed

Feasibility Study of Adjuvant Treatment With S-1 in Patients After R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction (S-1 adjuvant)

Adenocarcinoma,Stomach | Adenocarcinoma, Esophagogastric Junction

Germany

Clinical Trials Sponsored by Ebewe Pharma GmbH

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations